EPA-DHA Extra Strength® Enteric Coated
Natural health product licensed in Canada
- Other names
- OmegaGenics EPA-DHA 500
- Licence holder
- Metagenics Inc.
- NPN or DIN-HM
- 80015229
- Status
- Inactive licence
- Licence date
- 15 December 2009
- Revision date
- 30 June 2014
- Form
- Capsule (entéro soluble)
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Huile de poisson Source : Sardine Potency : 300 mg EPA | 980 mg | Not calculated |
| Huile de poisson Source : Sardine Potency : 200 mg DHA | Not specified | Not calculated |
| Huile de poisson Source : Anchois Potency : 300 mg EPA | 980 mg | Not calculated |
| Huile de poisson Source : Anchois Potency : 200 mg DHA | Not specified | Not calculated |
Non-medicinal ingredients
Vanillin, Polypropylene glycol, Tocophérol, Poly(sorbate) 80, Romarin, Glycérine, Palmitate d'ascorbyle, Eau, Copolymère d'acide méthacrylique, Monostéarate de glycéryle, Triacétine, (p)-hydroxybenzoate de propyle, Citrate de triéthyle, (p)-hydroxybenzoate de méthyle, Gélatine, Saveur de citron naturelle
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Enfants | minimum: 9 years ; maximum: 13 years | 4 Gélule | Not specified |
| Enfants | minimum: 14 years ; maximum: 18 years | 5 Gélule | Not specified |
| Adultes | Not specified | 6 Gélule | Not specified |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps support the development of the brain, eyes, and nerves in children up to 12 years of age. To help support cognitive and cardiovascular health, and help reduce serum triglycerides. In conjuction with conventional therapy, to help reduce the pain of rheumatoid arthritis in adults.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80015229
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2014. Photograph the packaging to check whether it has changed. Photograph the packaging